Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tisagenlecleucel
Indolent Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P1
CC
(41)
Tisagenlecleucel
Waldenstrom Macroglobulinemia
Memorial Sloan Kettering Cancer Center
P1
CC
(41)
Valemetostat
Small Cell Lung Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(41)
VIPIVOTIDE TETRAXETAN
Diffuse Glioma, H3 G34 Mutant
Memorial Sloan Kettering Cancer Center
P1
CC
(41)
VIPIVOTIDE TETRAXETAN
IDH-Wildtype Glioblastoma
Memorial Sloan Kettering Cancer Center
P1
CC
(41)
Camonsertib
Metastatic Malignant Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Capecitabine
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Copanlisib
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Icasp9M28Z T Cell Infusions
Lung Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Mezigdomide
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Mezigdomide
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Neratinib
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Neratinib
Lymphoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
SC16.56
Small Cell Lung Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
TRASTUZUMAB
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Trastuzumab Emtansine
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
Icasp9M28Z T Cell Infusions
Breast Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(40)
Mezigdomide
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(40)
Mirdametinib
Breast Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(40)
Pertzye
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(40)
1928z1xx trac t cell
B-Cell Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P1
C
(39)
1928z1xx trac t cell
Large B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
P1
C
(39)
64Cu-Tz-SarAr
Malignant Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(39)
[68ga]psma
Urinary Bladder Carcinoma
Memorial Sloan Kettering Cancer Center
P1
C
(39)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells
Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1
C
(39)
Showing 476 to 500 of 603 assets
Previous
Page 20 of 25
Next
